- Home
- Publications
- Publication Search
- Publication Details
Title
An update of safety of clinically used atypical antipsychotics
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 15, Issue 10, Pages 1329-1347
Publisher
Informa UK Limited
Online
2016-06-27
DOI
10.1080/14740338.2016.1201475
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia
- (2016) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Maximizing clozapine utilization while minimizing blood dyscrasias
- (2016) Tammie Lee Demler et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Clozapine-induced myocarditis, a widely overlooked adverse reaction
- (2015) K. J. Ronaldson et al. ACTA PSYCHIATRICA SCANDINAVICA
- Post-Injection Delirium/Sedation Syndrome after Olanzapine Long-Acting Intramuscular Injection - Who is at Risk?
- (2015) Magdalena Łukasik-Głębocka et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice
- (2015) Chris J Bushe et al. BMC Psychiatry
- High-Dose Risperidone Induced Latent Syndrome of Inappropriate Antidiuretic Hormone Secretion With Seizure Presentation
- (2015) Yen-Feng Lee et al. CLINICAL NEUROPHARMACOLOGY
- Antipsychotic Drug Use and the Risk of Seizures: Follow-up Study with a Nested Case–Control Analysis
- (2015) Marlene Bloechliger et al. CNS DRUGS
- Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
- (2015) Andrea de Bartolomeis et al. CNS DRUGS
- Treatment of clozapine-associated weight gain: a systematic review
- (2015) Z. Whitney et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Olanzapine depot exposure in male rats: Dose-dependent lipogenic effects without concomitant weight gain
- (2015) J. Fernø et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects
- (2015) Amilton dos Santos Júnior et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Miocarditis aguda secundaria a clozapina
- (2015) Javier Molina Martín de Nicolás et al. MEDICINA CLINICA
- Clinical Management of Antipsychotic-Induced Hyperprolactinemia
- (2015) Choochart Wong-Anuchit PERSPECTIVES IN PSYCHIATRIC CARE
- Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology
- (2015) Leonel E. Rojo et al. PHARMACOLOGICAL RESEARCH
- The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach
- (2015) Christoffer Polcwiartek et al. PSYCHOPHARMACOLOGY
- Clozapine-Induced Myocarditis: Prevention and Considerations in Rechallenge
- (2015) Sarah C. Cook et al. PSYCHOSOMATICS
- QTc modification after risperidone administration – insight into the mechanism of action with use of the modeling and simulation at the population level approach
- (2015) Anna Glinka et al. TOXICOLOGY MECHANISMS AND METHODS
- Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
- (2015) Martino Belvederi Murri et al. Drugs in research & development
- Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability – a review
- (2015) Rosa Catalán et al. Patient Preference and Adherence
- QTc modification after risperidone administration – insight into the mechanism of action with use of the modeling and simulation at the population level approach
- (2015) Anna Glinka et al. TOXICOLOGY MECHANISMS AND METHODS
- Severe adverse reactions associated with quetiapine
- (2015) D. Degner BMJ-British Medical Journal
- Severe adverse reactions associated with quetiapine
- (2015) D. Degner BMJ-British Medical Journal
- Seizure Associated with Clozapine: Incidence, Etiology, and Management
- (2014) Andrew M. Williams et al. CNS DRUGS
- A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults
- (2014) Leslie Citrome et al. CURRENT MEDICAL RESEARCH AND OPINION
- Weight gain and antipsychotics: a drug safety review
- (2014) Richard Musil et al. Expert Opinion On Drug Safety
- Safety of antipsychotic drugs: focus on therapeutic and adverse effects
- (2014) Felix-Martin Werner et al. Expert Opinion On Drug Safety
- A systematic review of clozapine induced cardiomyopathy
- (2014) Mohammed Alawami et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia
- (2014) Joseph P. McEvoy et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clozapine-Related Pericarditis During Titration Phase in a Patient With Resistant Schizophrenia and Concomitant Valproate Treatment
- (2014) Domenico De Berardis et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Naturalistic Comparison of the Long-Term Metabolic Adverse Effects of Clozapine Versus Other Antipsychotics for Patients With Psychotic Illnesses
- (2014) Anne C. Kelly et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Management of Psychosis and Agitation in Medical-Surgical Patients Who Have or Are at Risk for Prolonged QT Interval
- (2014) ROSE RIES et al. Journal of Psychiatric Practice
- Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia
- (2014) Marcin Kołaczkowski et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Clozapine, a Fast-Off-D2 Antipsychotic
- (2013) Philip Seeman ACS Chemical Neuroscience
- Use of anticonvulsants as prophylaxis for seizures in patients on clozapine
- (2013) Dorgival Caetano Australasian Psychiatry
- Signalling profile differences: paliperidone versus risperidone
- (2013) W P Clarke et al. BRITISH JOURNAL OF PHARMACOLOGY
- Paliperidone Extended-Release: Safety and Tolerability from a Metabolic Profile Perspective
- (2013) Alfonso Rodríguez-Martínez et al. CLINICAL DRUG INVESTIGATION
- Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study
- (2013) Leslie Citrome et al. CNS SPECTRUMS
- Adverse Effects of Clozapine in Older Patients: Epidemiology, Prevention and Management
- (2013) Delia Bishara et al. DRUGS & AGING
- Lethal neuroleptic malignant syndrome due to amisulpride
- (2013) Frank Musshoff et al. Forensic Science Medicine and Pathology
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Clozapine-associated pneumonia and respiratory arrest secondary to severe constipation
- (2013) Nuwan Galappathie et al. MEDICINE SCIENCE AND THE LAW
- Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial
- (2013) Antony Loebel et al. SCHIZOPHRENIA RESEARCH
- Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
- (2013) Pemberton et al. Neuropsychiatric Disease and Treatment
- Incidence and time course of extrapyramidal symptoms with oral and long-acting injectable paliperidone: a posthoc pooled analysis of seven randomized controlled studies
- (2013) Srihari Gopal et al. Neuropsychiatric Disease and Treatment
- A review of the use of clozapine levels to guide treatment and determine cause of death
- (2012) Anne Stark et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Clozapine-induced myocarditis and baseline echocardiography
- (2012) Kathlyn J Ronaldson et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Long-term safety and tolerability of lurasidone in schizophrenia
- (2012) Leslie Citrome et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate
- (2012) Itziar Montalvo et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A Thorough QTc Study of 3 Doses of Iloperidone Including Metabolic Inhibition Via CYP2D6 and/or CYP3A4 and a Comparison to Quetiapine and Ziprasidone
- (2012) Steven G. Potkin et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Atypical Neuroleptic Malignant Syndrome Associated with Iloperidone Administration
- (2012) Nicole Guanci et al. PSYCHOSOMATICS
- Paliperidone Palmitate for Schizophrenia
- (2012) A. M. Nussbaum et al. SCHIZOPHRENIA BULLETIN
- Critical appraisal of lurasidone in the management of schizophrenia
- (2012) Silvio Caccia et al. Neuropsychiatric Disease and Treatment
- Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
- (2011) Herbert Y. Meltzer et al. AMERICAN JOURNAL OF PSYCHIATRY
- Tardive Meige′s syndrome associated with olanzapine
- (2011) Ashish Aggarwal et al. Annals of Indian Academy of Neurology
- A New Monitoring Protocol for Clozapine-Induced Myocarditis Based on an Analysis of 75 Cases and 94 Controls
- (2011) Kathlyn J. Ronaldson et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Iloperidone, Asenapine, and Lurasidone: A Brief Overview of 3 New Second-Generation Antipsychotics
- (2011) Leslie Citrome POSTGRADUATE MEDICINE
- Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties
- (2011) Adrian Newman-Tancredi et al. PSYCHOPHARMACOLOGY
- Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
- (2011) Steven G. Potkin et al. SCHIZOPHRENIA RESEARCH
- Clinical potential of lurasidone in the management of schizophrenia
- (2011) L Samalin et al. Therapeutics and Clinical Risk Management
- All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors
- (2010) Philip Seeman CNS Neuroscience & Therapeutics
- Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
- (2010) Richard Mailman et al. CURRENT PHARMACEUTICAL DESIGN
- Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention
- (2010) Ofer Agid et al. EXPERT OPINION ON PHARMACOTHERAPY
- Gastrointestinal hypomotility: An under-recognised life-threatening adverse effect of clozapine
- (2010) R.J. Flanagan et al. FORENSIC SCIENCE INTERNATIONAL
- Acute akathisia with quetiapine: A case report and review of literature
- (2010) Sandeep Grover et al. INDIAN JOURNAL OF PHARMACOLOGY
- Asenapine for long-term treatment of bipolar disorder: A double-blind 40-week extension study
- (2010) Roger S. McIntyre et al. JOURNAL OF AFFECTIVE DISORDERS
- Risperidone Long-Acting Injection: Pharmacokinetics Following Administration in Deltoid Versus Gluteal Muscle in Schizophrenic Patients
- (2010) An Thyssen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation
- (2010) Stephen R. Marder et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia
- (2010) Gahan J. Pandina et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Amisulpride Overdose Is Frequently Associated With QT Prolongation and Torsades de Pointes
- (2010) Geoffrey K. Isbister et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Tardive oculogyric crisis associated with amisulpride monotherapy
- (2010) DN Mendhekar et al. Journal of Postgraduate Medicine
- A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia
- (2010) S Gopal et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism
- (2010) Shikha Snigdha et al. PSYCHOPHARMACOLOGY
- Risk Factors for Ileus in Patients with Schizophrenia
- (2010) J. Nielsen et al. SCHIZOPHRENIA BULLETIN
- Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: Involvement of dopamine D1 receptors
- (2010) Kent Jardemark et al. SYNAPSE
- New atypical antipsychotics for schizophrenia: iloperidone
- (2010) Silvio Caccia Drug Design Development and Therapy
- Using oral ziprasidone effectively: the food effect and dose-response
- (2009) Leslie Citrome ADVANCES IN THERAPY
- Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs
- (2009) Julian N. Trollor et al. CNS DRUGS
- Lurasidone: a new drug in development for schizophrenia
- (2009) Jonathan M Meyer et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic
- (2009) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Olanzapine-Induced Tardive Oculogyric Crisis
- (2009) Samir Kumar Praharaj et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms
- (2009) Olivia Frånberg et al. PSYCHOPHARMACOLOGY
- Asenapine effects in animal models of psychosis and cognitive function
- (2009) Hugh M. Marston et al. PSYCHOPHARMACOLOGY
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo
- (2009) Atheir I. Abbas et al. PSYCHOPHARMACOLOGY
- Evaluating the association between clozapine and venous thromboembolism
- (2008) C. A. Paciullo AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Extrapyramidal side-effects of antipsychotics in a randomised trial
- (2008) Del D. Miller et al. BRITISH JOURNAL OF PSYCHIATRY
- The use of ziprasidone in clinical practice: Analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey
- (2008) Friederike Vogel et al. EUROPEAN PSYCHIATRY
- Aripiprazole Treatment Causes Extrapyramidal Side Effects But Not Prolactin Elevation: A Disconnect of the Striatal D2 Occupancy Story
- (2008) Joo-Cheol Shim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Safety Profile of Iloperidone
- (2008) Peter J. Weiden et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Asenapine induces differential regional effects on serotonin receptor subtypes
- (2008) FI Tarazi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
- (2008) M. Shahid et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: A pooled analysis of data from the pivotal trials
- (2008) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- Cognitive dysfunction in neuropsychiatric disorders: Selected serotonin receptor subtypes as therapeutic targets
- (2007) Alvin V. Terry et al. BEHAVIOURAL BRAIN RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started